After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Kymera Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Kymera Therapeutics Inc is $3.07B. A total of 0.85 million shares were traded on the day, compared to an average of 868.79K shares.
In the most recent transaction, Esposito Pamela sold 5,000 shares of KYMR for 49.04 per share on Jun 03 ’25. After the transaction, the Director now owns 0 company shares. In a previous transaction on Jun 03 ’25, Ridloff Elena sold 12,000 shares at 46.10 per share. KYMR shares that Director owns now total 0.
Among the insiders who sold shares, Mainolfi Nello disposed of 30,000 shares on Jun 03 ’25 at a per-share price of $49.00. This resulted in the Chief Executive Officer holding 660,482 shares of KYMR after the transaction. In another insider transaction, Albers Jeffrey W. sold 6,349 shares at $49.00 per share on Jun 03 ’25. Company shares held by the Director now total 0.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, KYMR has a high of $53.27 and a low of $19.44.
As of this writing, KYMR has an earnings estimate of -$0.86 per share for the current quarter. EPS was calculated based on a consensus of 15.0 estimates, with a high estimate of -$0.31 per share and a lower estimate of -$1.08.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. KYMR’s latest balance sheet shows that the firm has $442.42M in Cash & Short Term Investments as of fiscal 2021. There were $17.96M in debt and $92.54M in liabilities at the time. Its Book Value Per Share was $12.07, while its Total Shareholder’s Equity was $459.64M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KYMR is Buy with a score of 4.90.
